The data displays the OTC (over-the-counter) revenue of female contraceptives in the U.S. from 2011 to 2017. In 2013, OTC revenue of female contraceptives in the U.S. reached around 241 million USD.
2011 | 216 |
2012 | 225 |
2013 | 241 |
2014 | 274 |
2015 | 313 |
2016 | 338 |
2017 | 366 |